Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.66 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.50 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.50 |
| ▸ | LPAR5 | Q9H1C0 | 4/20 | 0.50 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.50 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.50 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.49 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.47 |
| ▸ | PRKCG | P05129 | 1/20 | 0.47 |
| ▸ | PRKCB | P05771 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 1/20 | 0.47 |
| ▸ | PRKCH | P24723 | 1/20 | 0.47 |
| ▸ | PRKCI | P41743 | 1/20 | 0.47 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6428917 | 1.00 | USP2 (0.66) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL9081739 | 1.00 | USP2 (0.66) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL3422793 | 1.00 | USP2 (0.66) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL6431402 | 1.00 | USP2 (0.66) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL15412325 | 1.00 | USP2 (0.66) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL6429702 | 1.00 | USP2 (0.66) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL16004728 | 1.00 | USP2 (0.66) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL15412716 | 1.00 | USP2 (0.66) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL6428812 | 1.00 | USP2 (0.66) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL2390480 | 1.00 | USP2 (0.66) | USP2HTTMEN1THRBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8912365-B2 | Process for preparing a polyol ether | FONDS DE DEVELOPPEMENT DES FILIERES DES OLEAGINEUX ET PROTEAGINEUX FIDOP (FR) | 2014-12-16 | — | — | US | disclosed |
| US-20140018579-A1 | PROCESS FOR PREPARING A POLYOL ETHER | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2014-01-16 | — | — | US | disclosed |
| US-20050043402-A1 | Methods and formulations for counteracting infection of mucosa or skin | LIPOMEDICA EHF. (IS) | 2005-02-24 | — | — | US | disclosed |
| US-6596763-B1 | Method for counteracting infections caused by bacteria, fungi or virus such as Herpes Simplex Virus in skin or mucosal membranes, in particular genital membranes, of a mammal. The method comprises topically administering to skin or mucous | LIPOMEDICA EHF. (IS) | 2003-07-22 | — | — | US | disclosed |
| EP-0941087-A1 | TOPICAL FORMULATIONS CONTAINING AS A THERAPEUTIC ACTIVE AGENT FATTY ACIDS OR FATTY ALCOHOLS OR MONOGLYCERIDE DERIVATIVES THEREOF FOR TREATING OF MUCOSA INFECTIONS | Thormar, Halldor (IS) | 1999-09-15 | — | — | EP | disclosed |
| WO-1998020872-A1 | TOPICAL FORMULATIONS CONTAINING AS A THERAPEUTIC ACTIVE AGENT FATTY ACIDS OR FATTY ALCOHOLS OR MONOGLYCERIDE DERIVATIVES THEREOF FOR TREATING OF MUCOSA INFECTIONS | THORMAR HALLDOR (IS) | 1998-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140018579-A1 | PROCESS FOR PREPARING A POLYOL ETHER | RER1, CYP2F1, CYP2E1 | USP2 1337/4885HTT 4499/4885MEN1 819/4885 |
| US-20050043402-A1 | Methods and formulations for counteracting infection of mucosa or skin | MGLL, GK, UGCG | USP2 1597/4885HTT 3992/4885MEN1 1080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.